Progyny
Founded Year
2008Stage
IPO | IPOTotal Raised
$59.02MDate of IPO
10/25/2019Market Cap
3.57BStock Price
34.21Revenue
$0000About Progyny
Progyny (NASDAQ: PGNY) is a fertility benefits management company. It offers members a comprehensive value-based treatment plan that is based on medical science and technology. The benefit covers fertility treatments and provides support for adoption and surrogacy. It was founded in 2008 and is based in New York, New York.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Research containing Progyny
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Progyny in 2 CB Insights research briefs, most recently on Nov 11, 2022.
Nov 11, 2022 report
How tech is making women’s healthcare more equitable and accessible
Expert Collections containing Progyny
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Progyny is included in 2 Expert Collections, including Digital Health.
Digital Health
10,553 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Women's Health Tech
481 items
This collection includes companies applying technology to address a spectrum of physical, mental, and social well-being concerns specific to women. Examples include companies in reproductive health, maternal care, fertility tracking, and menopause support.
Progyny Patents
Progyny has filed 7 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/17/2015 | 7/18/2017 | Developmental biology, Statistical classification, Classification algorithms, Embryology, Stem cells | Grant |
Application Date | 9/17/2015 |
|---|---|
Grant Date | 7/18/2017 |
Title | |
Related Topics | Developmental biology, Statistical classification, Classification algorithms, Embryology, Stem cells |
Status | Grant |
Latest Progyny News
Aug 28, 2023
In a move designed to address an often-overlooked health concern, Progyny, a pioneering company in benefits management for fertility and family building, has broadened its managed reproductive health network to include specialized menopause care. This expansion aims to fill a significant healthcare gap, offering crucial support for employees undergoing menopause and perimenopause. Progyny has teamed up with Gennev and Midi Health, two…
Progyny Frequently Asked Questions (FAQ)
When was Progyny founded?
Progyny was founded in 2008.
Where is Progyny's headquarters?
Progyny's headquarters is located at 1359 Broadway, New York.
What is Progyny's latest funding round?
Progyny's latest funding round is IPO.
How much did Progyny raise?
Progyny raised a total of $59.02M.
Who are the investors of Progyny?
Investors of Progyny include SR One, TPG Biotech, Kleiner Perkins Caufield & Byers, Mellon Ventures, Union Grove Venture Partners and 3 more.
Who are Progyny's competitors?
Competitors of Progyny include Visana Health, Kindbody, Maven, Sapyen, Univfy and 7 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Progyny to Competitors
Kindbody operates a fertility clinic network. It develops a fertility and family-building care platform offering reproductive care from preconception to postpartum through menopause. The company was founded in 2018 and is based in New York, New York.
Carrot is a fertility care platform for women. The company's customized plans are recognized for their inclusivity, price transparency, and focus on healthier outcomes. It was founded in 2016 and is based in Menlo Park, California.
Maven operates as a digital health clinic for women. It offers a mobile application providing users access to instant video appointments and private messaging with healthcare practitioners. It provides solutions from preconception support to fertility preservation, in vitro fertilization (IVF), adoption, surrogacy, and more. The company was founded in 2014 and is based in New York.
Future Family operates as a fertility care company. It offers subscription plans for In vitro fertilization (IVF) and egg freezing, with on-demand medical support through Concierge Care. The company was founded in 2016 and is based in San Francisco, California.
Univfy applies AI/machine learning to help women and couples navigate their family-building options with cost-savings and greater success. The Univfy AI Platform provides scientifically-validated, personalized reports that counsel patients upfront about their personalized success rates to support smarter budgeting and treatment planning. By integrating clinical and financial counseling tools, Univfy helps providers increase their efficiency and growth.
Apricity is a virtual fertility clinic that offers treatment and nurses to patients. It provides an application that features injection and appointment reminders, guidance videos, and articles. Primarily it offers consultation, fertility treatment, and conservation services such as egg freezing, sperm freezing, embryo freezing, egg donation, egg donor search, and match, egg donor match and screen and embryology. The company was founded in 2018 and is based in London, United Kingdom.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
